Lantheus Holdings (LNTH) Other Non Operating Income (2014 - 2026)
Lantheus Holdings (LNTH) posted quarterly Other Non Operating Income of $5.7 million for Q1 2026, up 7420.51% year-over-year from $75925.7 in Q1 2025, and up 1901.26% quarter-over-quarter from -$317000.0 in Q4 2025.
Lantheus Holdings (LNTH) Other Non Operating Income (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has reported Other Non Operating Income for 13 consecutive years, with $5.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non Operating Income rose 7420.51% year-over-year to $5.7 million; the TTM figure through Mar 2026 stood at $4.8 million (up 2188.21% YoY), while the FY2025 annual figure was -$1.0 million, down 1624.24% from the prior year.
- Other Non Operating Income advanced to $5.7 million in Q1 2026 per LNTH's latest filing, from -$317000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $52.6 million in Q3 2023 and bottomed at -$58.2 million in Q4 2023.
- Historically, Other Non Operating Income has averaged $856058.8 across 5 years, with a median of $46000.0 in 2024.
- Annual changes were most pronounced in 2023 — Other Non Operating Income tumbled 9607.33% — and 2026, when it surged 7420.51%.
- Lantheus Holdings' Other Non Operating Income stood at -$600000.0 in 2022, then sank by 9607.33% to -$58.2 million in 2023, then surged by 100.44% to $258000.0 in 2024, then sank by 222.87% to -$317000.0 in 2025, then jumped by 1901.26% to $5.7 million in 2026.
- Business Quant data shows LNTH's Other Non Operating Income at $5.7 million in Q1 2026, -$317000.0 in Q4 2025, and -$269000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Lantheus Holdings | 6.54 Bn | 5.94 Bn | 241.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.86 Mn |
| Mar 31, 2026 | 5.71 Mn |
| Dec 31, 2025 | -317,000.00 |
| Sep 30, 2025 | -269,000.00 |
| Jun 30, 2025 | -342,000.00 |
| Mar 31, 2025 | -78,000.00 |
| Dec 31, 2024 | 258,000.00 |
| Sep 30, 2024 | 46,000.00 |
| Jun 30, 2024 | -455,000.00 |
| Mar 31, 2024 | 8.79 Mn |
| Dec 31, 2023 | -58.24 Mn |
| Sep 30, 2023 | 52.65 Mn |
| Jun 30, 2023 | 4.48 Mn |
| Mar 31, 2023 | 3.23 Mn |
| Dec 31, 2022 | -600,000.00 |
| Sep 30, 2022 | -1.10 Mn |
| Jun 30, 2022 | 310,000.00 |
| Mar 31, 2022 | 485,000.00 |
| Sep 30, 2021 | -3.94 Mn |
| Jun 30, 2021 | 182,000.00 |